Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine

Name: Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine
SKU: 23028
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 49 No. 2 Articles 2019 Tags: Agastya Nayar, antipsychotics, feras-ali-mustafa, long acting injectable olanzapine, schizophrenia, tardive-dyskinesia

Description

Description

Letters to the Editor

Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine

By Feras Ali Mustafa, Agastya Nayar

Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine

Description

Letters to the Editor

Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders

Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine

Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia

Antipsychotics Case Study by Yuan-Hwa Chou

Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine

Description

Letters to the Editor

Related products

Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders

Karen L. Hall, MD: Neuroleptic Malignant Syndrome Due to Olanzapine

Cocaine is a Major Risk Factor for Antipsychotic Induced Akathisia, Parkinsonism and Dyskinesia

Antipsychotics Case Study by Yuan-Hwa Chou